Blog

Home/Blog

Recent studies show virusPHIX+ inactivates and stabilises SARS-CoV-2

We are proud to be partnering with a number of laboratories around the world for the validation of virusPHIX+™ as a viral transport medium for SARS-CoV-2 testing. Virus Inactivation A recent study from the Roslin Institute in Edinburgh, UK concluded that virusPHIX+™ inactivates SARS-CoV-2 in as little as 10 minutes when treated at a 1:1 [...]

2020-09-22T14:42:45+01:00September 22nd, 2020|

Sanger Institute creates the first cell atlas of mosquito immune cells with the help of vivoPHIX

  Congratulations to Gianmarco Raddi, PhD on the publication of ‘Mosquito cellular immunity at single-cell resolution’ in Science. The study discusses the discovery of new types of mosquito immune cells, including a rare cell type that could be involved in limiting malaria infection, as well as identifying molecular pathways implicated in controlling the malaria parasite. [...]

2020-09-04T16:26:09+01:00September 4th, 2020|

Rapid Labs Ltd secure £80,000 grant from Tendring District Council

Rapid Labs have been awarded an £80,000 grant from Tendring District Council to increase production capacity at their biomedical facility in Little Bentley. The grant has contributed towards the cost of a new ISO 8 clean room facility, which is primarily being used for the manufacture and development of a novel RNA stabiliser and virus [...]

2020-08-17T10:44:58+01:00August 17th, 2020|

Rapid Labs become members of the British In Vitro Diagnostics Association (BIVDA)

We are pleased to announce that Rapid Labs Ltd have been awarded membership of the British In Vitro Diagnostics Association (BIVDA). BIVDA is the national industry association for the manufacturers and distributors of IVD products in the UK and currently represent more than 95% of the industry and over a hundred organisations ranging from British [...]

2020-07-30T16:47:10+01:00July 30th, 2020|

Rapid Labs launches online shop for CentriVet Products

We are delighted to inform customers that you can now purchase our CentriVet range directly from our website. Our new online shop allows customers to order CentriVet products by credit/debit card, making it easier and more convenient to purchase products. Previously customers would have to fill out an enquiry form on our website to speak [...]

2020-07-10T16:05:05+01:00July 10th, 2020|

Viruses and bacteria successfully inactivated by virusPHIX, vivoPHIX and genoPHIX RNA stabilisation reagents

RNAssist Ltd., is a technology development company based in Cambridge UK specialised in biomolecule stabilisation and microbial inactivation. The range includes genoPHIX™ (for large tissue samples), vivoPHIX™ (for work involving single cell analysis) and virusPHIX™ (for the safe transport and handling of virus samples). Our lead product virusPHIX™ has been shown to stabilise RNA, DNA [...]

2020-06-25T16:50:15+01:00June 23rd, 2020|

Zika Virus Successfully Inactivated Using VivoPHIX

The Pasteur Institute has successfully demonstrated inactivation of the Zika Virus using vivoPHIX™: To determine the ability of vivoPHIX™ to inhibit ZIKV in mosquito tissue sample, ZIKV-infected mosquito midguts were dissected at 6 dpi. Mosquito midguts were then chopped into 3-4 small pieces then transfer into vivoPHIX™. Samples were then treated at 4 degree Celsius [...]

2020-06-17T16:16:26+01:00June 17th, 2020|

New vivoPHIX publication in Current Osteoporosis Reports

Single-cell analysis is an expanding technology offering unique perspectives into transcriptional functions of individual cells. In contrast with bulk RNAseq that analyses the entire RNA content of a biological sample regardless of the cell of origin of the transcript, scRNA-seq first relies on the successful isolation of live cells from the sample, and separation of [...]

2020-06-10T14:42:49+01:00June 10th, 2020|

From Cat 3 to a Cat 2 Laboratory: How virusPHIX helped the Pasteur Institute with their work on Dengue Virus

Containment laboratories are designed to prevent or control the exposure of laboratory workers, other persons and the environment to the biological agent in use. These laboratories have been categorised into four hazard groups, CL1, CL2, CL3 and CL4. CL1 is deemed the lowest risk, with CL4 classed as the highest. Each level containment laboratory has [...]

2020-05-29T16:12:08+01:00May 29th, 2020|